Our sibling publication, G2 Intelligence, reported in May about a new Department of Justice (DOJ) memorandum that indicated prosecutors will seek to exercise fairness when deciding how to pursue fraud cases against clinical laboratories and other organizations. The DOJ emphasized the need for greater transparency about how parties that self-disclose their fraud problems and cooperate […]
To access this post, you must purchase The Dark Report.